Santhosh K
Department of Shalakya Tantra, Yenepoya Ayurveda Medical College and Hospital, Naringana, Derlakatte (Post), Mangaluru, Karnataka, 575018, India.
J Ayurveda Integr Med. 2024 Nov-Dec;15(6):100991. doi: 10.1016/j.jaim.2024.100991. Epub 2024 Nov 29.
This is a case report of a 60-year-old male, who was a patient of Benign Prostate Hyperplasia since 2019, diagnosed as having Hypertriglyceridemia (Serum Triglycerides-839 mg/dL) after routine screening in a Diagnostic Laboratory. Although these were two distinct disease entities, Charaka Samhita's concept of Srotas was taken into consideration for treatment, and drugs that reduced both Serum Triglyceride levels and Lower Urinary Tract Symptoms (LUTS) of BPH were chosen. Varanadi Kashaya and Shilajitvadi Bati were given as medicines and after one month of follow-up, Serum Triglycerides decreased to 283 mg/dL, and improvement in the form of reduction of hesitancy during urination was appreciated by the patient. Over the course of the next one and a half years, the patient's serum triglycerides level was monitored with the same two medicines, along with the addition of Vastyamayantaka Ghritam and improvement was seen at each follow-up appointment. Therefore, in people with obesity and disorders of urinary system, the medicines which act on the kidneys can be selected, since they serve as the common origin for Medovaha Srotas and Mutravaha Srotas.
这是一例60岁男性的病例报告,该患者自2019年起患有良性前列腺增生,在一家诊断实验室进行常规筛查后被诊断为高甘油三酯血症(血清甘油三酯-839mg/dL)。尽管这是两种不同的疾病实体,但在治疗时考虑了《阇罗迦本集》中关于“输罗陀”(Srotas)的概念,并选择了既能降低血清甘油三酯水平又能缓解良性前列腺增生下尿路症状(LUTS)的药物。给予了瓦拉纳迪煎剂(Varanadi Kashaya)和施罗基特瓦迪丸剂(Shilajitvadi Bati)作为药物,经过一个月的随访后,血清甘油三酯降至283mg/dL,并观察到患者排尿犹豫症状减轻。在接下来的一年半时间里,使用这两种药物监测患者的血清甘油三酯水平,并加用了瓦斯特亚玛扬塔卡酥油(Vastyamayantaka Ghritam),每次随访均可见病情改善。因此,对于肥胖和泌尿系统疾病患者,可以选择作用于肾脏的药物,因为它们是“蜜道输罗陀”(Medovaha Srotas)和“尿道输罗陀”(Mutravaha Srotas)的共同起源。